pWT1126–134 vaccines for myeloid leukemia have been investigated in several studies [43,44], and pWT137–45-specific CD8+ T cells of high avidity have been detected in patients with myeloid leukemia [32]. This evidence concerns the gene CD8A and myeloid leukemia.